Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem pharmacokinetics and safety in infants with bacterial meningitis
2011-001521-25Phase 2Completed
- Sponsor
- Penta Foundation
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of meropenem in bacterial meningitis, sponsored by Penta Foundation. Primary endpoints: Meropenem pharmacokinetics and Safety. Started Sep 2011; status: completed.
02
Drugs
meropenem
03
Conditions
bacterial meningitis
Beyond the preview
Go deeper on 2011-001521-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001521-25.